Oxycodon Accord (Oxycodone Hydrochloride Ph. Eur.)

Oxycodone Hydrochloride, the active ingredient in Oxycodon Accord, is an opioid analgesic presented as a solid oral dosage form for systemic use. It is prescribed for the management of moderate to severe pain in adult patients when alternative treatments are inadequate.

GNH USA supplies Oxycodon Accord as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals and pharmacies worldwide.

Oxycodon Accord is an opioid that acts on the central nervous system to relieve pain across several clinical settings.

- Cancer‑related pain: provides sustained relief of moderate to severe tumor‑associated pain. - Post‑operative pain: helps control pain following major surgical procedures. - Chronic non‑cancer pain: used when long‑term opioid therapy is deemed appropriate for conditions such as severe osteoarthritis. - Acute injury pain: alleviates intense pain from traumatic injuries or fractures. - Palliative care: contributes to comfort in end‑of‑life care where pain control is a priority.

Oxycodon Accord may cause a range of adverse reactions that vary in frequency and severity.

Common Side Effects: - Constipation: reduced gastrointestinal motility leading to hard stools. - Nausea: feeling of queasiness often accompanied by an upset stomach. - Drowsiness: mild sedation or feeling of tiredness. - Dizziness: light‑headed sensation, especially when standing quickly. - Dry mouth: decreased salivation causing a parched feeling. - Itching: mild skin pruritus without rash.

Serious or Rare Side Effects: - Respiratory depression: slowed breathing that can be life‑threatening. - Severe hypotension: marked drop in blood pressure causing faintness. - Opioid use disorder: risk of dependence, tolerance, and addiction. - Seizures: rare occurrence of convulsive episodes. - Allergic reactions: hives, swelling, or anaphylaxis. - adrenal ​  

Oxycodon